Epigral Ltd Technical Momentum Shifts Amid Bearish Signals

Recent Price Movement and Market Context

On 31 Jul 2026, Epigral Ltd closed at ₹1,106.30, down 1.74% from the previous close of ₹1,125.85. The stock traded within a range of ₹1,100.65 to ₹1,133.25 during the day, reflecting heightened volatility. This price action comes amid a broader technical trend shift from mildly bearish to bearish, underscoring growing selling pressure. The stock remains significantly below its 52-week high of ₹2,114.30, while comfortably above its 52-week low of ₹806.20, indicating a wide trading band over the past year.

Technical Indicator Analysis: MACD, RSI, and Moving Averages

The Moving Average Convergence Divergence (MACD) indicator presents a mixed picture. On a weekly basis, the MACD remains mildly bullish, suggesting some short-term positive momentum. However, the monthly MACD is bearish, indicating that longer-term momentum is weakening. This divergence between weekly and monthly MACD readings often signals caution for investors, as short-term rallies may be countered by sustained downward pressure over the medium term.

The Relative Strength Index (RSI) on both weekly and monthly charts currently shows no clear signal, hovering in neutral territory. This lack of momentum confirmation from RSI suggests that the stock is neither overbought nor oversold, leaving room for further directional movement based on other technical factors.

Moving averages on the daily chart are firmly bearish, reinforcing the prevailing downtrend. The stock price remains below key moving averages, which typically act as resistance levels in a declining market. This bearish alignment of moving averages signals that the stock is likely to face continued selling pressure unless it can decisively break above these averages.

Additional Technical Signals: Bollinger Bands, KST, Dow Theory, and OBV

Bollinger Bands on the weekly chart indicate sideways movement, reflecting a consolidation phase with limited directional conviction. However, the monthly Bollinger Bands are mildly bearish, suggesting that volatility may increase to the downside over a longer horizon.

The Know Sure Thing (KST) indicator aligns with the broader bearish narrative, showing mildly bearish signals on the weekly chart and bearish readings monthly. This momentum oscillator’s deterioration confirms weakening price strength and supports the view of a sustained downtrend.

Dow Theory analysis reveals no clear trend on the weekly timeframe, but a mildly bearish stance on the monthly scale. This mixed signal implies that while short-term price swings may lack direction, the medium-term outlook remains cautious.

On-Balance Volume (OBV) shows no discernible trend on either weekly or monthly charts, indicating that volume flow is not currently confirming price movements. This absence of volume confirmation often precedes more volatile price action as market participants await clearer directional cues.

Comparative Performance: Epigral Ltd vs Sensex

Epigral’s recent returns have lagged behind the benchmark Sensex, highlighting relative underperformance. Over the past week, Epigral declined by 3.7%, while the Sensex gained 2.01%. Over one month, the stock posted a modest 1.83% gain, slightly below the Sensex’s 1.90% rise. Year-to-date, Epigral is down 9.27%, marginally worse than the Sensex’s 8.56% decline.

More concerning is the one-year return, where Epigral has plummeted 46.95%, starkly contrasting with the Sensex’s modest 4.36% loss. This significant underperformance over the past year underscores the challenges faced by the company and the sector. However, over a three-year horizon, Epigral has delivered a 19.74% return, slightly outperforming the Sensex’s 17.79%, suggesting some resilience in the longer term.

Mojo Score and Ratings Update

MarketsMOJO’s proprietary scoring system currently assigns Epigral a Mojo Score of 37.0, categorising it as a Sell. This represents an upgrade from the previous Strong Sell rating issued on 26 Dec 2025, reflecting a slight improvement in technical and fundamental parameters. Despite this upgrade, the score remains low, signalling caution for investors considering fresh exposure.

The company’s market capitalisation is classified as small-cap, which typically entails higher volatility and risk compared to larger peers. Investors should weigh this factor alongside the technical signals before making portfolio decisions.

Investor Takeaway and Outlook

Epigral Ltd’s technical indicators collectively point to a challenging near-term outlook. The bearish alignment of daily moving averages, combined with monthly MACD and KST bearish signals, suggests that the stock may continue to face downward pressure. The absence of strong RSI signals and neutral OBV readings imply that the market is currently indecisive, awaiting clearer catalysts.

Given the stock’s significant underperformance relative to the Sensex over the past year and its small-cap status, investors should exercise caution. While the recent upgrade from Strong Sell to Sell indicates some stabilisation, the overall technical and momentum picture remains subdued.

Long-term investors might find value in the stock’s three-year outperformance versus the benchmark, but short- to medium-term traders should monitor key technical levels closely. A decisive break above daily moving averages and a sustained improvement in monthly MACD could signal a potential reversal. Until then, the prevailing bearish momentum warrants a conservative approach.

Summary of Key Technical Metrics:

• Current Price: ₹1,106.30
• 52-Week Range: ₹806.20 - ₹2,114.30
• Daily Moving Averages: Bearish
• Weekly MACD: Mildly Bullish
• Monthly MACD: Bearish
• RSI (Weekly & Monthly): No Signal
• Bollinger Bands (Weekly): Sideways; (Monthly): Mildly Bearish
• KST (Weekly): Mildly Bearish; (Monthly): Bearish
• Dow Theory (Weekly): No Trend; (Monthly): Mildly Bearish
• OBV (Weekly & Monthly): No Trend
• Mojo Score: 37.0 (Sell)

Investors should continue to monitor these technical parameters alongside fundamental developments within the specialty chemicals sector to gauge future price momentum and risk.

Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today